Drug intelligence / Profile preview

RoboFlam DS

Development stage
Unknown
Lead developer
Healthon Life Sciences
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

RoboFlam DS is a combination analgesic and anti-inflammatory medication developed and marketed by Healthon Lifesciences in India. The formulation typically contains the proteolytic enzymes Bromelain and Trypsin, the flavonoid antioxidant Rutoside, and in some versions, Devil's claw extract. The enzymes work synergistically to reduce inflammation and edema by breaking down inflammatory mediators and fibrin, thereby improving blood circulation to the affected site. Rutoside acts as an antioxidant to neutralize reactive oxygen species and stabilize capillary walls, preventing further swelling. This medication is primarily used to manage musculoskeletal pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as for recovery from post-operative pain, sprains, and bone fractures.

Brand names
RoboFlam DSRoboflam-DS
02

Targets

Fibrin (Factor Ia)

Beyond the preview

Go deeper on RoboFlam DS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RoboFlam DS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call